None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children younger than 19 years old with swallowing difficulties who underwent VFSS from February 2012 to July 2014 were recruited in this retrospective study. All of the enrolled children were evaluated by neuroimaging involving more than one brain magnetic resonance imaging (MRI) and/or ultrasonography (US). Children who showed swallowing difficulties due to diseases of the central nervous system (CNS), cardiopulmonary diseases (CPD), and congenital syndromes or delayed development (DD) of unknown etiology were included. CNS diseases were verified via abnormalities on a brain MRI or US.
Exclusion criteria
Exclusion criteria: Children who had incomplete medical records or who were not evaluated by brain MRI or US were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose area product (DAP);Effective dose | — |
Secondary
| Measure | Time frame |
|---|---|
| gender;height;weight;Body mass index;body surface area;underlying disease;duration of videofluoroscopic swallow study (VFSS);videofluoroscopic swallow study (VFSS) result | — |
Countries
Korea, Republic of
Contacts
Ulsan Univeristy Hospital